The unofficial approval-action numbers for ANDAs improved a bit from last month’s seventy, with the OGD hitting a total of full- and tentative-approval actions of seventy-eight. This breaks down to seventy‑two full-approval actions and six tentative-approval actions. These numbers are as of the morning of March 5, 2021 from the FDA’s All Approvals list (here).
In a short month with one holiday, that is pretty good. We will confirm the numbers when the OGD issues its official numbers in about a week or so.